Nancy Valente - 05 Nov 2021 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
MYOV
Transactions as of
05 Nov 2021
Transactions value $
$0
Form type
4
Filing time
09 Nov 2021, 16:15:43 UTC
Next filing
09 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYOV Stock Option (Right to Buy) Award $0 +36,892 $0 36,892 05 Nov 2021 Common Shares 36,892 $22.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the shares underlying the option vest and become exercisable on November 5, 2022, with the balance of the shares vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the vesting date.